Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $34.4 Million - $46.4 Million
497,000 New
497,000 $34.4 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $58.3 Million - $66.3 Million
-784,696 Reduced 63.44%
452,204 $37.4 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $71 Million - $90.9 Million
1,039,800 Added 527.55%
1,236,900 $92.3 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $16.2 Million - $21.1 Million
197,100 New
197,100 $16.3 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $591,368 - $744,372
-5,800 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $22.2 Million - $27.3 Million
-208,600 Reduced 97.29%
5,800 $751,000
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $21.2 Million - $25.3 Million
206,300 Added 2546.91%
214,400 $24.3 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $25.1 Million - $31.4 Million
-299,900 Reduced 97.37%
8,100 $839,000
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $24.2 Million - $27.9 Million
308,000 New
308,000 $25.8 Million
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $2.66 Million - $3.38 Million
-37,100 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $57 Million - $74.2 Million
-848,300 Reduced 95.81%
37,100 $2.96 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $27.7 Million - $37 Million
480,700 Added 118.78%
885,400 $61.2 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $13.9 Million - $21.5 Million
265,470 Added 190.67%
404,700 $76.3 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $9.98 Million - $11.4 Million
139,230 New
139,230 $32.5 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.